WebApr 13, 2024 · About CSL. CSL is a leading global biotechnology company with a dynamic portfolio of life-saving medicines, including those that treat haemophilia and immune deficiencies, as well as vaccines to prevent influenza. Since our start in 1916, we have been driven by our promise to save lives through innovation. Learn more about CSL.
Summer 2024 – Quality Assurance Intern @ CSL Simplify
WebCSL's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 44x. In other words, CSL shares trade at around 44x recent earnings. That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2024 (32.14). WebApr 13, 2024 · Joanne Tran Markets Reporter. Apr 13, 2024 – 2.11pm. Clare Coleman is co-portfolio manager of Fidelity International Australian Opportunities Fund. framery trenton
Shareholder Services CSL Limited
WebThe CSL Ltd share price lagged the S&P/ASX 200 Index in the first quarter of 2024.. Shares in the ASX 200 biotechnology company closed out 2024 trading for $287.76. When the … WebShare the Latino and Rare Experience. With Sesiones de Escucha NORD, The National Organization for Rare Disorders invites the Hispanic patient community to discuss … Web2 days ago · CSL Ltd shares first listed on the ASX way back on 8 June 1994. The S&P/ASX 200 Index biotechnology company floated for $2.30 per share. But once we … blake\\u0027s place catering